Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Zaleplon (Sonata) and Belsomra (suvorexant) are both medications used to treat insomnia, but they work in different ways and have some key differences. Zaleplon is a sedative-hypnotic that helps you fall asleep by working on gamma-aminobutyric acid (GABA) receptors in your brain. It is available as a lower-cost generic and is best for short-term use, up to 30 days. On the other hand, Belsomra is an orexin receptor antagonist that helps you fall and stay asleep by blocking the action of orexin, a chemical that promotes wakefulness. Belsomra is only available as a brand-name medication, making it more expensive. Both medications can be habit-forming and are controlled substances, but Belsomra is noted for potentially causing sleep paralysis and muscle weakness in the legs. Zaleplon may cause unusual sleep behaviors like sleep-walking or sleep-driving. While both medications can cause drowsiness the next day, Belsomra is generally considered a safer option for the elderly.
Zaleplon
Belsomra (suvorexant)
Zaleplon
Belsomra (suvorexant)
Summary of Sonata vs. Belsomra
Summary for Sedative-hypnotic
Prescription only
Zaleplon, once sold under the brand name Sonata, is a prescription sleep medication for adults. It helps with insomnia (trouble falling asleep). It's a type of sedative-hypnotic called a non-benzodiazepine, or "z-drug." You take it by mouth right before bed or when you're already in bed and can't fall asleep. Zaleplon is a controlled substance because it has a risk of misuse and dependence. Side effects can include headache and dizziness.
Summary for Orexin receptor antagonist
Prescription only
Belsomra (suvorexant) is used to treat insomnia in adults. It's helpful for those who have a hard time falling asleep or staying asleep. This sleep medication belongs to the drug class called orexin receptor antagonists. You take a dosage within 30 minutes of bedtime as needed for sleep. It's common to feel drowsy the next day as a side effect. Belsomra (suvorexant) is a controlled substance because of the risk of misuse and becoming habit-forming. It's available as a brand-name medication only.